Downloads: 0 | Views: 62
Review Papers | Cancer Science | India | Volume 11 Issue 6, June 2022
Prostate Cancer Screening Approach as Well Disease Burden and its Precision Medicine Outlook Purely in Indian Context
Abstract: Risk of clinically significant prostate cancer is related to age, family history, PSA level, free and total PSA ratio as well as finding of digital rectal examination DRE, subclinical prostate cancer is common in men over 50 years of age, hence PSA (Prostate specific Antigen) testing Hs been recommended in men over 60years of age if PSA level is more than 2ng/ml. The 5 - year survival rate for prostate cancer in India is 64%. Although many cancer deem fit for cancer screening but prostate cancer screening having limited role author will try described about current recommendation of prostate cancer screening , recent data of HBCR Hospital based cancer registry shall also be discussed in order to understand disease burden in Indian context. Recently precision medicine has open its wings for prostate cancer as well what we achieve out of it shall further addressed in this review article.
Keywords: Screening test, Cancer registry in India, Precision medicine, Prostate cancer
Edition: Volume 11 Issue 6, June 2022,
Pages: 1577 - 1578